Llama antibodies open door to future coronavirus protection
24 June, 2025Researchers have discovered a novel class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous SARS-CoV-2 variants.
Bio-Rad Laboratories anti-idiotypic antibodies and Human IgM-FcSpyCatcher reagent
19 June, 2025Bio-Rad Laboratories has extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to pertuzumab (Perjeta), guselkumab (Tremfya), canakinumab (Ilaris), belimumab (Benlysta) and the bispecific drug emicizumab (Hemlibra).
ProSci Incorporated apoptosis antibodies
05 June, 2025ProSci Incorporated provides an extensive catalogue of apoptotic antibodies including death receptors (DR4, DR5), Bcl-2 family member proteins (Bad, Bax, Bim, Puma), caspase family proteins, p53 signalling pathway, and apoptosis regulatory molecules and enzymes.
Super-strong antibodies developed for cancer treatment
16 May, 2025Scientists discovered that their antibody prototype, which was more rigid, was able to trigger a stronger response from the immune system compared to those made by our bodies.
Newly created antivenom protects against 19 deadly snakes
06 May, 2025By using antibodies from a human donor with a self-induced hyper-immunity to snake venom, US researchers claim to have developed the most broadly effective antivenom to date.
Testing more antibodies with fewer lab mice
02 April, 2025Researchers have developed a technology that can be used to test 25 antibodies simultaneously in a single laboratory mouse.
Proteintech FcZero recombinant antibodies for flow cytometry
06 March, 2025Proteintech has designed recombinant antibodies featuring the company's FcZero backbone, engineered to silence the Fc domain for clean flow cytometry data.
FUJIFILM Irvine Scientific Shenandoah Cytokines
05 March, 2025FUJIFILM Irvine Scientific provides recombinant cytokines to the academic and industrial scientific research communities. A wide variety of recombinant human, mouse and rat cytokines are available.
Proteintech matched antibody pairs
16 January, 2025Proteintech's matched antibody pairs are validated using the company's proprietary in-house multiplex bead array technology and sandwich ELISA platforms.
LSBio PathPlus Neuroscience Antibodies
08 January, 2025LSBio PathPlus Neuroscience Antibodies are suitable for immunohistochemistry (IHC) applications in neuroscience and neurobiology.
Biosensis GAPDH antibodies
11 December, 2024Biosensis offers two types of GAPDH antibodies: a mouse monoclonal antibody (Cat #M-1376) and a rabbit polyclonal antibody (Cat #R-1701). These antibodies were specifically developed against highly purified pig GAPDH.
Proteintech Genomics MultiPro Human Discovery Panel
01 November, 2024The MultiPro Human Discovery Pane allowis researchers to explore proteins located both within the intracellular compartments and on the surface of cells.
LSBio PathPlus Cancer Antibodies
07 October, 2024The LSBio PathPlus Cancer series of antibodies include both well-established biomarkers of cancer (cancer pathology markers) as well as those that are used in asking a broader series of questions about the aetiology, subclassification and pathogenesis of cancer (cancer molecular markers).
Monoclonal antibody shows protection against COVID variants
17 September, 2024A monoclonal antibody appears effective at neutralising the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to spread in people.
GeneTex G protein-coupled receptor (GPCR) antibodies
06 September, 2024GeneTex's goal is to produce the most extensive line of antibodies for human G protein-coupled receptors (GPCRs).
